期刊文献+

β肾上腺素受体对心肌细胞钙信号的调控 被引量:1

Regulation ofβ-adrenergic receptors on cardiomyocyte calcium signaling
原文传递
导出
摘要 心脏是血液循环的动力器官.心肌细胞通过钙致钙释放的机制实现兴奋收缩耦联,控制着心脏有节律的收缩和舒张.交感神经递质通过β肾上腺素受体(β-adrenergic receptor, βAR)调控心肌细胞钙信号转导和心脏收缩舒张功能.在病理条件下, βAR的信号转导和钙信号出现异常,导致心律失常、心力衰竭、缺血再灌注损伤等心脏疾病的发生.因此,阐明βAR信号通路对心肌细胞钙信号的调节对认识心脏疾病的机理和药物研发具有重要意义. The heart pumps blood rhythmically to the entire body relying on the excitation-contraction coupling initiated by the calcium-inducedcalcium release process in cardiomyocyte. Sympathetic neurotransmitters bind with β-adrenergic receptors (βARs) to regulatecardiomyocyte calcium signaling as well as the contraction and relaxation function of the heart. Under pathological conditions,abnormal βAR and calcium signaling leads to heart diseases such as arrhythmia, heart failure and ischemia-reperfusion injury.Therefore, elucidating the βAR regulation of calcium signaling in cardiomyocytes is important for understanding heart diseasemechanisms and for developing drug treatments.
作者 任宇捷 梁景辉 侯婷婷 王世强 REN YuJie;LIANG JingHui;HOU TingTing;WANG ShiQiang(State Key Laboratory of Membrane Biology,College of Life Sciences,Peking University,Beijing 100871,China)
出处 《中国科学:生命科学》 CSCD 北大核心 2024年第8期1346-1359,共14页 Scientia Sinica(Vitae)
基金 国家自然科学基金(批准号:92254301,32230048,32250003)资助。
关键词 心肌细胞 Β肾上腺素受体 钙信号转导 cardiomyocyte β-adrenergic receptor calcium signaling
  • 相关文献

参考文献1

二级参考文献89

  • 1Beigi F, Bertucci C, Zhu W, Chakir K, Wainer IW, Xiao RP, et al.Enantioselective separation and online affinity chromatographic characterization of R,R- and S,S-fenoterol. Chirality 2006; 18: 822-7.
  • 2Jozwiak K, Khalid C, Tanga MJ, Berzetei-Gurske I, Jimenez L, Kozocas JA, et al. Comparative molecular field analysis of the binding of the stereo isomers of fenoterol and fenoterol derivatives to the β2 adrenergic receptor. J Med Chem 2007; 50: 2903-15.
  • 3Woo AY, Wang TB, Zeng X, Zhu W, Abernethy DR, Wainer IW, et al. Stereochemistry of an agonist determines coupling preference of 132-adrenoceptor to different G proteins in cardiomyocytes. Mol Pharmacol 2009; 75: 158-65.
  • 4Seifert R, Dove S. Functional selectivity of GPCR ligand stereoisomers: new pharmacological opportunities. Mol Pharmacol 2009; 75: 13-8.
  • 5Jozwiak K, Woo AY, Tanga MJ, Toll L, Jimenez L, Kozocas JA, et al. Comparative molecular field analysis of fenoterol derivatives: A platform towards highly selective and effective β2-adrenergic receptor agonists. Bioorg Med Chem 2010; 18: 728-36.
  • 6Talan MI, Ahmet I, Xiao RP, Lakatta EG. β2AR in the treatment of congestive heart failure: long path to translation. J Mol Cell Cardiol 2011; 51: 529-33.
  • 7Mangmool S, Shukla AK, Rockman HA. I3-Arrestin-dependent activation of Ca^2+/calmodulin kinase II after 131-adrenergic receptor stimulation. J Cell Biol 2010; 189: 573-87.
  • 8Zhu W, Woo AY, Yang D, Cheng H, Crow MT, Xiao RP. Activation of CaMKlloC is a common intermediate of diverse death stimuli-induced heart muscle cell apoptosis. J Biol Chem 2007; 282: 10833-9.
  • 9Ling H, Zhang T, Pereira L, Means CK, Cheng H, Gu y, et al. Requirement for Ca^2+/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice. J Clin Invest 2009; 119: 1230-40.
  • 10Van Oort RJ, McCauley MD, Dixit SS, Pereira L, Yang Y, Respress JL, et al. Ryanodine receptor phosphorylation by calcium/calmodulindependent protein kinase" promotes life-threatening ventricular arrhythmias in mice with heart failure. Circulation 2010; 122: 2669- 79.

共引文献27

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部